Real‐World Experience With a Suprannular Self‐Expanding Transcatheter Aortic Valve: The ALLOW Study
Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 1826-1834
DOI: 10.1002/ccd.70538 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 04.03.2026. Verfasst von Ignacio Cruz-González und 15 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínico Universitario de Salamanca, CIBERCV (Centro de Investigaciones Cardiovasculares en Red), IBSAL (Instituto de Investigación Biomédia …. Hauptthemen laut MEDLINE: Heart Valve Prosthesis, Aortic Valve, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Transcatheter aortic valve replacement (TAVR) has evolved significantly, expanding its indication to lower surgical risk patients. However, challenges remain, including conduction disorders or paravalvular leak (PVL). The ALLEGRA TAVI system (Biosensors International) is a supra‐annular self‐expanding prosthesis designed to optimize implantation and hemodynamic performance.
Aims
The objective of this study was to analyze short‐term outcomes following the implantation of the Allegra valve in real‐world practice.
Methods
This multicenter retrospective study included 500 patients who underwent TAVR with the Allegra valve across 11 Spanish centers between 2017 and 2024. Success rates, complications, and 30‐day clinical outcomes were analyzed.
Results
The median age was 82.1 ± 5.5 years. The overall success rate was 96.8% (95% CI 94.8%−98.0%), with complications in 11.6% (95% CI 8.0%−13.0%) of cases. The need for permanent pacemaker implantation (PPI) was 19.2% (95% CI 16.0%−22.9%), while moderate‐to‐severe PVL occurred in 4.1% (95% CI 2.7%−6.3%). The in‐hospital mortality rate was 1.0% (95% CI 0.5%−2.6%). Hemodynamic performance was favorable, with post‐implant mean gradients of 4.0 mmHg (IQR 2.0−5.0 mmHg) in native aortic stenosis and 7.0 mmHg (IQR 5.0−10.0 mmHg) in valve‐in‐valve procedures. A reduction in complications was observed, but not significantly, with increased experience (15.2% vs. 10.4%, p 0.147), though without impact on success rates.
Conclusions
This study confirms that the Allegra valve is a safe and effective TAVR option, with outcomes comparable to other self‐expanding prostheses. Further design optimization could reduce PVL and PPI rates. Long‐term studies are needed to assess durability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Clínico Universitario de Salamanca, CIBERCV (Centro de Investigaciones Cardiovasculares en Red), IBSAL (Instituto de Investigación Biomédia de Salamanca), Salamanca, Spain.
- Cardiology Department, La Paz University Hospital, Madrid, Spain.
- Fundación de Investigación IDIPAZ, CIBERCV (Centro de Investigaciones Cardiovasculares en Red), Madrid, Spain.
- Complejo Hospitalario Universitario Alvaro Cunqueiro, Vigo, Spain.
- Servicio de Cardiología, Hospital Universitario de Toledo, Toledo, Spain.
- Cardiology Department, Complejo Hospital Universitario de Santiago, CIBERCV (Centro de Investigaciones Cardiovasculares en Red), Santiago de Compostela, Spain.
ORCID-Profile: Pablo Antúnez-Muiños, Víctor A Jiménez Díaz, Rafael Romaguera, Jorge Sanz Sánchez, Claudio E Guerreiro
Zitieren
APA
Cruz-González, I., Antúnez-Muiños, P., Galeote, G., Jiménez Díaz, V. A., Rubio, C., Trillo, R., Romaguera, R., Ruiz-Nodar, J. M., Sanz Sánchez, J., Alonso-Briales, J. H., Gheorghe, L. L., Jiménez-Quevedo, P., Guerreiro, C. E., Moreno, R., Moreu, J., & Baz, J. A. (2026). Real‐World Experience With a Suprannular Self‐Expanding Transcatheter Aortic Valve: The ALLOW Study. Catheterization and Cardiovascular Interventions, 107(6), 1826-1834. https://doi.org/10.1002/ccd.70538
Vancouver
Cruz-González I, Antúnez-Muiños P, Galeote G, Jiménez Díaz VA, Rubio C, Trillo R, et al. Real‐World Experience With a Suprannular Self‐Expanding Transcatheter Aortic Valve: The ALLOW Study. Catheterization and Cardiovascular Interventions. 2026;107(6):1826-1834. doi:10.1002/ccd.70538
BibTeX
@article{CruzGonzlez2026,
author = {Cruz-González, Ignacio and Antúnez-Muiños, Pablo and Galeote, Guillermo and Jiménez Díaz, Víctor A and Rubio, Canton and Trillo, Ramiro and Romaguera, Rafael and Ruiz-Nodar, Juan M and Sanz Sánchez, Jorge and Alonso-Briales, Juan Horacio and Gheorghe, Livia L and Jiménez-Quevedo, Pilar and Guerreiro, Claudio E and Moreno, Raúl and Moreu, José and Baz, Jose Antonio},
title = {Real‐World Experience With a Suprannular Self‐Expanding Transcatheter Aortic Valve: The ALLOW Study},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
volume = {107},
number = {6},
pages = {1826--1834},
doi = {10.1002/ccd.70538}
}
EUVIMED